Journal of Nanomedicine & Nanotechnology

Abstract

Nanotechnology in Osteoporosis Treatment: Present Strategies and Future Horizons

Maria Gallicchio*

Osteoporosis poses a significant public health burden worldwide, characterized by bone fragility and increased fracture risk, particularly among aging populations. Conventional treatment modalities for osteoporosis, while beneficial, often come with limitations such as systemic side effects and suboptimal efficacy. Nanotechnology presents a promising avenue for overcoming these challenges, offering precise drug delivery, enhanced therapeutic efficacy, and reduced adverse effects. This article provides an overview of the current landscape of nanotechnology in osteoporosis treatment, highlighting existing strategies and emerging prospects for future advancements. Current practices include nanostructured drug delivery systems, targeted drug delivery approaches, stimuli-responsive nanosystems, and bone regeneration nanotherapeutics. Despite significant progress, challenges related to biocompatibility, scalability, and regulatory approval remain. Looking ahead, personalized nanomedicine, theranostic nanoplatforms, and multifunctional nanocomposites offer exciting opportunities for revolutionizing osteoporosis treatment. Continued research and collaborative efforts are essential for translating these innovative concepts into clinical practice, ultimately improving the management and outcomes of osteoporotic patients globally.

Published Date: 2024-03-31; Received Date: 2024-03-01